1. Home
  2. METCB vs AKBA Comparison

METCB vs AKBA Comparison

Compare METCB & AKBA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Ramaco Resources Inc. Class B

METCB

Ramaco Resources Inc. Class B

HOLD

Current Price

$11.82

Market Cap

836.9M

Sector

Energy

ML Signal

HOLD

Logo Akebia Therapeutics Inc.

AKBA

Akebia Therapeutics Inc.

HOLD

Current Price

$1.61

Market Cap

729.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
METCB
AKBA
Founded
2015
2007
Country
United States
United States
Employees
N/A
N/A
Industry
Coal Mining
Biotechnology: Pharmaceutical Preparations
Sector
Energy
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
836.9M
729.1M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
METCB
AKBA
Price
$11.82
$1.61
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$38.69
$6.25
AVG Volume (30 Days)
96.0K
4.0M
Earning Date
10-27-2025
11-10-2025
Dividend Yield
6.71%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$579,503,000.00
$225,071,000.00
Revenue This Year
N/A
$52.38
Revenue Next Year
$21.27
$22.45
P/E Ratio
N/A
N/A
Revenue Growth
N/A
32.49
52 Week Low
$5.86
$1.45
52 Week High
$21.80
$4.08

Technical Indicators

Market Signals
Indicator
METCB
AKBA
Relative Strength Index (RSI) 40.59 40.49
Support Level $11.10 $1.45
Resistance Level $12.78 $1.61
Average True Range (ATR) 0.85 0.08
MACD 0.08 0.05
Stochastic Oscillator 22.17 62.75

Price Performance

Historical Comparison
METCB
AKBA

About METCB Ramaco Resources Inc. Class B

Ramaco Resources Inc is a United States-based company that operates as a pure-play metallurgical coal company with operations in southern West Virginia and southwestern Virginia. Its portfolio includes high-quality metallurgical coal reserves & resources, with a focus on properties such as Elk Creek, Berwind, Knox Creek, and Maben. These properties are strategically located to serve North American blast furnace steel mills and coke plants, as well as international metallurgical coal consumers. Additionally, the company controls mineral deposits in Sheridan, Wyoming, exploring potential opportunities in rare earth elements and coal-to-carbon-based products. Operations are concentrated in the Appalachian basin, with active mines at Elk Creek, Berwind, Knox Creek, and Maben mining complexes.

About AKBA Akebia Therapeutics Inc.

Akebia Therapeutics Inc is a fully integrated biopharmaceutical company. The Company's operating segment is the business of developing and commercializing novel therapeutics for people with kidney disease. The current portfolio of the company includes Auryxia (ferric citrate), a medicine approved and marketed in the United States for the control of serum phosphorus levels in adult patients with dialysis-dependent chronic kidney disease and the treatment of iron deficiency anemia, in adult patients with non-dialysis-dependent chronic kidney disease, Vafseo (vadadustat), an oral hypoxia-inducible factor prolyl hydroxylase, inhibitor approved in Japan for the treatment of anemia due to chronic kidney disease, in adult patients, HIF-PH inhibitors in preclinical development.

Share on Social Networks: